Keywords: Analysis/Processing, Low-Field MRI, ULF MRI, Ultra-Low-Field MRI, Deep Learning, Unpaired Image Translation, Brain Segmentation, Vision Transformers, CycleGAN
Motivation: The image quality of ultra-low-field MRI impacts the reliability of volumetric analysis in the brain. Existing techniques that address this issue learn from synthetically generated images, leading to a domain shift problem when presented with real images.
Goal(s): Development of a deep learning method trained with real ULF and HF images to robustly generate an image that can be segmented with routine software tools.
Approach: We introduce a CycleGAN framework with Residual Vision Transformers to improve super-resolved images compared to existing methods.
Results: The accuracy of volumetric estimations improves using our method compared to others based on clinical correlations and test-retest reliability metrics.
Impact: Our new image enhancement method should allow reliable volumetric evaluation using ULF-MRI. This will allow investigators in regions with access to ULF systems to monitor brain health in a way that was previously unattainable.
1. Chetcuti, K., Chilingulo, C., Goyal, M. S., et al. Implementation of a Low-Field Portable MRI Scanner in a Resource-Constrained Environment: Our Experience in Malawi. AJNR: American Journal of Neuroradiology, 2022;43(5):670–674.
2. Mazurek, M. H., Cahn, B. A., Yuen, M. M., et al. Portable, bedside, low-field magnetic resonance imaging for evaluation of intracerebral hemorrhage. Nature Communications, 2021;12(1), Article 1.
3. Bermel, R. A., & Bakshi, R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. The Lancet Neurology, 2006;5(2):158–170.
4. Fox, N. C., & Schott, J. M. Imaging cerebral atrophy: Normal aging to Alzheimer’s disease. The Lancet, 2004;363(9406):392–394.
5. Swanson, C. J., Zhang, Y., Dhadda, S., et al. A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody. Alzheimer’s Research & Therapy, 2021;13(1):80.
6. van Dyck, C. H., Swanson, C. J., Aisen, P., et al. Lecanemab in Early Alzheimer’s Disease. The New England Journal of Medicine, 2023;388(1):9–21.
7. Lau, V., Xiao, L., Zhao, Y., et al. Pushing the limits of low-cost ultra-low-field MRI by dual-acquisition deep learning 3D superresolution. Magnetic Resonance in Medicine, 2023;90(2):400–416.
8. Lin, H., Figini, M., D’Arco, F., et al. Low-field magnetic resonance image enhancement via stochastic image quality transfer. Medical Image Analysis, 2023;87:102807.
9. Iglesias, J. E., Schleicher, R., Laguna, S., et al. (Accurate super-resolution low-field brain MRI. arXiv. 2022;2202.03564.
10. Iglesias, J. E., Billot, B., Balbastre, Y., et al. SynthSR: A public AI tool to turn heterogeneous clinical brain scans into high-resolution T1-weighted images for 3D morphometry. Science Advances, 2023;9(5):eadd3607.
11. Kimberly, W. T., Sorby-Adams, A. J., Webb, A. G., et al. Brain imaging with portable low-field MRI. Nature Reviews Bioengineering, 2023;1(9):Article 9.
12. Zhu, J.-Y., Park, T., Isola, P., & Efros, A. A. Unpaired Image-to-Image Translation using Cycle-Consistent Adversarial Networks. arXiv. 2020;1703.10593.
13. Dalmaz, O., Yurt, M., & Çukur, T. ResViT: Residual vision transformers for multi-modal medical image synthesis. IEEE Transactions on Medical Imaging, 2022;41(10):2598–2614.
14. He, K., Zhang, X., Ren, S., & Sun, J. Deep Residual Learning for Image Recognition. arXiv. 2015;1512.03385
15. Dosovitskiy, A., Beyer, L., Kolesnikov, A., Weissenborn, D., et al. An Image is Worth 16x16 Words: Transformers for Image Recognition at Scale. arXiv. 2021;2010.11929.
16. Lyu, M., Mei, L., Huang, S. et al. M4Raw: A multi-contrast, multi-repetition, multi-channel MRI k-space dataset for low-field MRI research. Scientific Data, 2023;10(1):Article 1.
17. Van Essen D. C., Smith S. M, Barch D. M., et al. The WU-Minn Human Connectome Project: An overview. NeuroImage 2013;80(2013):62-79.
18. Mazziotta, J. C., Toga, A. W., Evans, A., et al. A Probabilistic Atlas of the Human Brain: Theory and Rationale for Its Development: The International Consortium for Brain Mapping (ICBM). NeuroImage, 1995;2(2, Part A):89–101.
19. Avants, B. B., Tustison, N. J., Song, G.,et al. A reproducible evaluation of ANTs similarity metric performance in brain image registration. NeuroImage, 2011;54(3):2033–2044.
20. Tournier, J.-D., Smith R. E., Raffelt D., et al. MRtrix3: A fast, flexible and open software framework for medical image processing and visualization. NeuroImage 2019;202(2019):116–37.
21. Henschel, L., Conjeti, S., Estrada, S., et al. FastSurfer—A fast and accurate deep learning based neuroimaging pipeline. NeuroImage, 2020;219:117012.
22. van Nederpelt, D. R., Amiri, H., Brouwer, I., Noteboom, S., et al. Reliability of brain atrophy measurements in multiple sclerosis using MRI: An assessment of six freely available software packages for cross-sectional analyses. Neuroradiology, 2023;65(10):1459–1472.
23. Isensee, F., Schell, M., Tursunova, I., et al. Automated brain extraction of multi-sequence MRI using artificial neural networks. Human Brain Mapping, 2019;40(17):4952–4964.
24. McGraw, K. O., & Wong, S. P. Forming inferences about some intraclass correlation coefficients. Psychological Methods, 1996;1(1):30–46.